s , ▁and ▁commercial izes ▁innov ative ▁ph arma ce ut ical ▁and ▁bi ote chn ology ▁products . ▁Led ▁by ▁CE O ▁L inds ay ▁A . ▁Rosen wald , ▁M . D ., ▁Fort ress ▁and ▁most ▁of ▁its ▁subs idi ary ▁companies ▁are ▁head qu arter ed ▁in ▁New ▁York ▁City , ▁U . S .. ▁ ▁History ▁The ▁company ▁was ▁founded ▁in ▁ 2 0 0 6 ▁under ▁the ▁name ▁Cor on ado ▁B ios ci ences , ▁initially ▁as ▁an ▁on col ogy ▁company . ▁In ▁ 2 0 1 1 , ▁it ▁was ▁announced ▁that ▁Cor on ado ▁raised ▁$ 4 7 . 4 ▁million ▁in ▁fund ing . ▁Short ly ▁there after ▁it ▁became ▁a ▁public ▁company ▁by ▁register ing ▁all ▁of ▁its ▁private ▁shares ▁as ▁common ▁stock . ▁The ▁company ▁changed ▁its ▁name ▁to ▁Fort ress ▁Bi ote ch ▁in ▁April ▁ 2 0 1 5 . ▁ ▁In ▁November ▁ 2 0 1 9 , ▁Fort ress ▁Bi ote ch ▁was ▁ranked ▁number ▁ 1 0 ▁in ▁the ▁ 2 0 1 9 ▁Del o itte ▁Technology ▁Fast ▁ 5 0 0 ▁annual ▁rank ings . ▁ ▁Sub s idi aries ▁Fort ress ▁Bio ▁has ▁ 1 0 ▁bi oph arma ce ut ical ▁subs idi ary ▁companies ▁which ▁cover ▁a ▁range ▁of ▁medical ▁ther apy ▁areas , ▁including ▁potential ▁cancer ▁treat ments ▁and ▁ther ap ies ▁for ▁rare ▁dise ases ▁and ▁conditions . ▁These ▁subs idi aries ▁include ▁A ev itas ▁Th era